Factors Associated with the Use of Intermittent Preventive Treatment (IPTp) by Women During Pregnancy in Burkina Faso

Aristide Romaric Bado,Nicolas Méda,Hermann Badolo,Sathiyasusuman Appunni,Ibrahim Lougué,Mwinonè Hervé Hien

doi:10.11648/j.wjph.20210603.15

Abstract

Introduction: Malaria infection during pregnancy is more pronounced in endemic areas of sub-Saharan Africa and is a major risk factor for maternal and child morbidity and mortality. Intermittent preventive treatment in pregnancy (IPTp) is presented as an effective way of combating malaria. This study aims to identify the different factors that may influence the use of IPTp by pregnant women in Burkina Faso. Methods: The data used in this study were derived from two rounds of the Malaria Indicator Surveys (MISs) conducted in Burkina Faso in 2014 and 2017. The sample for this study consisted of women aged 15–49 years who had had a live birth in the two years prior to the survey and who might or might not have received IPTp doses. Data analysis was performed using the Stata 15 software. Bivariate analysis and a logistic regression model were used to determine the associated factors. Results: The study results show that 56% and 63% of pregnant women had received at least three or more doses of IPTp during pregnancy in 2014 and 2017, respectively. For the 2014 survey, religion, education level, household standard of living, region of residence and type of caregiver were the significant factors associated with receiving three or more doses of IPTp, while those in the 2017 survey were household standard of living, region of residence and access to malaria information. Conclusion: Plausible interventions to increase the reception of at least three doses of IPTp during pregnancy by explaining the benefits of SP could help to effectively control malaria in women and thus increase foetal and infant survival at birth.

Highlights

Malaria infection during pregnancy is more pronounced in endemic areas of sub-Saharan Africa and is a major risk factor for maternal and child morbidity and mortality
Bivariate and multivariate logistic regressions were used to estimate crude odds ratios (OR) and adjusted odds ratios to determine the factors associated with intermittent preventive treatment during pregnancy (IPTp) compliance
Regarding the factors associated with receiving at least three doses of IPTp during the last pregnancy (Table 3), it was found that religion, education level, household standard of living, region of residence and type of caregiver were the significant variables for the 2014 survey, while in the 2017 survey, the significant variables were household standard of living, region of residence and access to malaria information

Summary

Introduction

Malaria infection during pregnancy is more pronounced in endemic areas of sub-Saharan Africa and is a major risk factor for maternal and child morbidity and mortality. Morbidity and mortality caused by malaria infection during pregnancy are most pronounced in endemic regions of sub-Saharan Africa [1]. In this part of the world, malaria infection during pregnancy is a major risk factor for maternal and infant morbidity and mortality [2]. It causes maternal anaemia, which, when severe, increases the risk of maternal death [2, 3]. This approach is based on the use of chemoprophylaxis and insecticide-treated bed-nets and the appropriate management of malaria cases in pregnant women [4, 5]

Objectives

Methods

Results

Discussion

Conclusion